Obradović, D.D.; Milić, N.M.; Miladinović, N.; McClements, L.; Oprić, D.M.
Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice. Medicina 2022, 58, 1330.
https://doi.org/10.3390/medicina58101330
AMA Style
Obradović DD, Milić NM, Miladinović N, McClements L, Oprić DM.
Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice. Medicina. 2022; 58(10):1330.
https://doi.org/10.3390/medicina58101330
Chicago/Turabian Style
Obradović, Danilo D., Nataša M. Milić, Nenad Miladinović, Lana McClements, and Dejan M. Oprić.
2022. "Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice" Medicina 58, no. 10: 1330.
https://doi.org/10.3390/medicina58101330
APA Style
Obradović, D. D., Milić, N. M., Miladinović, N., McClements, L., & Oprić, D. M.
(2022). Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice. Medicina, 58(10), 1330.
https://doi.org/10.3390/medicina58101330